-
Genome-wide study of the effect of blood collection tubes on the cell-free DNA methylome
Study
EGAS00001004271
-
Characterization of Cell Free Plasma Methyl-DNA From Xenografted Tumors to Guide the Selection of Diagnostic Markers for Early-Stage Cancers
Study
EGAS00001006175
-
Non-invasive prenatal diagnosis by genome-wide haplotyping of maternal cell-free plasma DNA
Study
EGAS00001003634
-
Diagnosis of pediatric central nervous system tumors using methylation profiling of cfDNA from cerebrospinal fluid
Study
EGAS50000000377
-
Circulating cell-free DNA methylation profiles as noninvasive multiple sclerosis biomarkers: A proof-of-concept study
Study
EGAS50000001277
-
eMERGE Geisinger eGenomic Medicine (GeM) - MyCode Project Controls
Study
phs000381
-
A benchmark of DNA methylation deconvolution methods for tumoral fraction estimation using DecoNFlow
Study
EGAS50000001529
-
Targeted sequencing of cell free DNA samples from oligometastatic colorectal cancer patients
Study
JGAS000196
-
The Natural History of Mucolipidosis Type IV
Study
phs001329
-
shallow WGS of cell free DNA
Dataset
EGAD00001009796
-
Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader-Willi Syndrome
Study
phs001292
-
VIKING Health Study - Shetland
Study
EGAS00001003872
-
De novo mutations in cell-free foetal DNA (cffDNA)
Dataset
EGAD00001000596
-
Non-invasive prenatal diagnosis by genome-wide haplotyping of cell-free plasma DNA
Dataset
EGAD00001004989
-
Whole-genome sequencing of cell-free DNA from pancreatic and breast cancer cohorts for fragmentomic and tumor fraction analysis
Study
EGAS50000001620
-
Single cell RNAseq of stenotic, inflamed and non-inflamed transmural lesions from patients with Crohn's disease
Dataset
EGAD50000000559
-
Angiopredict: predicting response for bevacizumab treatment
Study
EGAS00001002724
-
A standardised framework for robust fragmentomic feature extraction from cell-free DNA sequencing data
Dataset
EGAD00001015535
-
Multimodal Epigenetic Sequencing Analysis (MESA) of Cell-free DNA for Non-invasive Cancer Detection
Study
EGAS00001006462
-
Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT-BioLINCC)
Study
phs003665
-
ctDNA Quantification in Blood Plasma Using Deep Learning Based Fragle Tool
Study
EGAS50000000122
-
Shallow whole genome sequencing of ctDNA samples from DETECT study
Study
EGAS50000000911
-
Epigenomics of Prostate Cancer from Cell Free Plasma
Study
phs003482
-
Study assessing the efficacy and safety of durvalumab plus olaparib plus fulvestrant in selected metastatic or locally advanced ER-positive, HER2-negative breast cancer patients.
Study
EGAS50000001166
-
Sensitive and robust liquid biopsy-based detection of PIK3CA mutations
Study
EGAS00001004940